Get Premium to unlock powerful stock data
Vaxart Inc logo

Vaxart Inc

$ 3.72 +0.2 (+5.68%) 10:08 PM EST
P/E:
At Loss
P/B:
2.83
Market Cap:
$ 470.38M
Enterprise V:
$ 335.64M
Volume:
3.72M
Avg Vol (2M):
2.66M
Also Trade In:
Volume:
3.72M
Market Cap $:
470.38M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.66M
Enterprise Value $:
335.64M
PB Ratio:
2.83
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Vaxart Inc
NAICS : 325414 SIC : 2836
170 Harbor Way, Suite 300, South San Francisco, CA, USA, 94080
Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 11.43
Equity-to-Asset 0.83
Debt-to-Equity 0.08
Debt-to-EBITDA -0.18
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.16
Distress
Grey
Safe
Beneish M-Score -4.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 65.18
9-Day RSI 55.29
14-Day RSI 50.2
6-1 Month Momentum % -36.36
12-1 Month Momentum % -35.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 13.97
Quick Ratio 13.97
Cash Ratio 13.38
Days Sales Outstanding 178.08

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -160.1

Financials (Next Earnings Date:2022-08-05 Est.)

VXRT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:VXRT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.471
EPS (TTM) ($) -0.64
Beta -0.18
Volatility % 104.21
14-Day RSI 50.2
14-Day ATR ($) 0.356888
20-Day SMA ($) 3.4855
12-1 Month Momentum % -35.63
52-Week Range ($) 2.49 - 10.33
Shares Outstanding (Mil) 126.45

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vaxart Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More